Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observation Study on the Efficacy of Yiqi Gubiao Pill in the Treatment of Chronic Obstructive Pulmonary Disease Secondary to Active Pulmonary Tuberculosis: A Double-Blind Randomized Controlled Trial Protocol

NCT06676800 is registered in ClinicalTrials.gov with Fourth Affiliated Hospital of Xinjiang Medical University as lead sponsor.

NCT NCT06676800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06676800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observation Study on the Efficacy of Yiqi Gubiao Pill in the Treatment of Chronic Obstructive Pulmonary Disease Secondary to Active Pulmonary Tuberculosis: A Double-Blind Randomized Controlled Trial Protocol
Lead sponsor
Fourth Affiliated Hospital of Xinjiang Medical University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
November 30, 2024
Completion date
March 31, 2025
Enrollment
74 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis-related obstructive pulmonary disease